"Mutagenesis, Insertional" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Mutagenesis where the mutation is caused by the introduction of foreign DNA sequences into a gene or extragenic sequence. This may occur spontaneously in vivo or be experimentally induced in vivo or in vitro. Proviral DNA insertions into or adjacent to a cellular proto-oncogene can interrupt GENETIC TRANSLATION of the coding sequences or interfere with recognition of regulatory elements and cause unregulated expression of the proto-oncogene resulting in tumor formation.
Descriptor ID |
D016254
|
MeSH Number(s) |
E05.393.420.601.550 G05.365.590.575 G05.558.550
|
Concept/Terms |
Sequence Insertion- Sequence Insertion
- Insertion, Sequence
- Insertions, Sequence
- Sequence Insertions
Gene Insertion- Gene Insertion
- Gene Insertions
- Insertion, Gene
- Insertions, Gene
Insertion Mutation- Insertion Mutation
- Insertion Mutations
- Mutation, Insertion
- Mutations, Insertion
Insertional Activation- Insertional Activation
- Activation, Insertional
- Activations, Insertional
- Insertional Activations
|
Below are MeSH descriptors whose meaning is more general than "Mutagenesis, Insertional".
Below are MeSH descriptors whose meaning is more specific than "Mutagenesis, Insertional".
This graph shows the total number of publications written about "Mutagenesis, Insertional" by people in this website by year, and whether "Mutagenesis, Insertional" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
1994 | 0 | 4 | 4 |
1995 | 0 | 4 | 4 |
1996 | 0 | 1 | 1 |
1997 | 0 | 3 | 3 |
1999 | 0 | 2 | 2 |
2000 | 1 | 3 | 4 |
2001 | 1 | 2 | 3 |
2002 | 0 | 4 | 4 |
2003 | 0 | 3 | 3 |
2004 | 0 | 4 | 4 |
2005 | 0 | 1 | 1 |
2006 | 1 | 3 | 4 |
2007 | 0 | 1 | 1 |
2008 | 1 | 0 | 1 |
2009 | 0 | 5 | 5 |
2010 | 1 | 1 | 2 |
2012 | 1 | 2 | 3 |
2013 | 2 | 1 | 3 |
2014 | 0 | 3 | 3 |
2015 | 1 | 2 | 3 |
2016 | 0 | 2 | 2 |
2017 | 1 | 4 | 5 |
2018 | 0 | 1 | 1 |
2020 | 1 | 0 | 1 |
2021 | 1 | 0 | 1 |
2022 | 0 | 2 | 2 |
2024 | 0 | 1 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Mutagenesis, Insertional" by people in Profiles.
-
Manakhov AD, Aarakelyan NA, Lapteacru AV, Andreeva TV, Trapezov OV, Rogaev EI. Genomic analysis links the American mink Royal pastel coat phenotype to retroviral element type 1 insertion in the HPS3 gene. Anim Genet. 2024 Oct; 55(5):788-792.
-
Hou Y, Cheng X, Witman GB. Direct in situ protein tagging in Chlamydomonas reinhardtii utilizing TIM, a method for CRISPR/Cas9-based targeted insertional mutagenesis. PLoS One. 2022; 17(12):e0278972.
-
Sarsani V, Aldikacti B, He S, Zeinert R, Chien P, Flaherty P. Model-based identification of conditionally-essential genes from transposon-insertion sequencing data. PLoS Comput Biol. 2022 03; 18(3):e1009273.
-
Murphy KC. Oligo-Mediated Recombineering and its Use for Making SNPs, Knockouts, Insertions, and Fusions in Mycobacterium tuberculosis. Methods Mol Biol. 2021; 2314:301-321.
-
Picariello T, Hou Y, Kubo T, McNeill NA, Yanagisawa HA, Oda T, Witman GB. TIM, a targeted insertional mutagenesis method utilizing CRISPR/Cas9 in Chlamydomonas reinhardtii. PLoS One. 2020; 15(5):e0232594.
-
Ou J, Liu H, Yu J, Kelliher MA, Castilla LH, Lawson ND, Zhu LJ. ATACseqQC: a Bioconductor package for post-alignment quality assessment of ATAC-seq data. BMC Genomics. 2018 03 01; 19(1):169.
-
Leroux M, Jani N, Sandler SJ. A priA Mutant Expressed in Two Pieces Has Almost Full Activity in Escherichia coli K-12. J Bacteriol. 2017 09 01; 199(17).
-
DeJesus MA, Nambi S, Smith CM, Baker RE, Sassetti CM, Ioerger TR. Statistical analysis of genetic interactions in Tn-Seq data. Nucleic Acids Res. 2017 Jun 20; 45(11):e93.
-
Flotte TR, Gao G. AAV Is Now a Medicine: We Had Better Get This Right. Hum Gene Ther. 2017 04; 28(4):307.
-
Mout R, Ray M, Lee YW, Scaletti F, Rotello VM. In Vivo Delivery of CRISPR/Cas9 for Therapeutic Gene Editing: Progress and Challenges. Bioconjug Chem. 2017 Apr 19; 28(4):880-884.